Recombinant vaccines for COVID-19

SARS-CoV-2, the causative agent of COVID-19, has imposed a major public health threat, which needs effective therapeutics and vaccination strategies. Several potential candidate vaccines being rapidly developed are in clinical evaluation. Considering the crucial role of SARS-CoV-2 spike (S) glycopro...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Hum Vaccin Immunother
Autori principali: Yadav, Tushar, Srivastava, Nishant, Mishra, Gourav, Dhama, Kuldeep, Kumar, Swatantra, Puri, Bipin, Saxena, Shailendra K
Natura: Artigo
Lingua:Inglês
Pubblicazione: Taylor & Francis 2020
Soggetti:
Mini Review
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7711739/
https://ncbi.nlm.nih.gov/pubmed/33232211
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2020.1820808
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi